PBMs Estimate Costs Of Restrictive Legislation; NCPA Urges “Education”
Executive Summary
Legislation requiring PBMs to disclose specific terms of contracts with manufacturers would increase Medicare prescription drug spending by 7%, an analysis commissioned by the Pharmaceutical Care Management Association maintains
You may also be interested in...
PBM Transparency: Three Firms Agree To Standards Set By Employer Group
Three pharmacy benefit management companies are in the vanguard of firms that have committed to giving up profits based on drug price differentials and rebates
PBM Transparency: Three Firms Agree To Standards Set By Employer Group
Three pharmacy benefit management companies are in the vanguard of firms that have committed to giving up profits based on drug price differentials and rebates
Medicare Rx Formulary Will Have More Than VA’s 30 Classes
The Medicare Part D model formulary will have more than the 30 therapeutic drug classes included in the Veterans Affairs formulary, Centers for Medicare & Medicaid Services Administrator Mark McClellan said at a National Health Council Medicare briefing in Washington, D.C. July 15